Impatient clinical development

While healthcare and disease-related charities raise enormous sums of money, it isn't always clear how much goes to research. When it does, the funds typically are used for academic and translational projects rather than clinical development. Newly formed not-for-profit Impatient is hoping to change that dynamic by allowing donors to earmark money for specific clinical trials.

Founder and acting CEO Rosamond Deegan told BioCentury that personal experience as a would-be donor was an important impetus for the charity. She found that most charities set aside only limited amounts of their budgets for research, typically in the academic setting. "There wasn't a way for me to earmark it for specific research," Deegan said...